Skip to main content

breast cancer Archives

Mathis strives to make her cancer journey meaningful

Nov. 9, 2017—Amanda Mathis, chief financial officer of Bridgestone Americas, was just 35 when she first felt a lump in her right breast.

Read more

Reporter


Study to test combination therapy for breast cancer

Oct. 26, 2017—Vanderbilt-Ingram Cancer Center (VICC) has received $2.3 million to fund a clinical research trial testing a combination of three immunotherapy compounds for patients with a specific type of advanced breast cancer.

Read more

Health and Medicine Reporter Research


My Southern Health: How to assess your breast cancer risk

Oct. 20, 2017—Do you know what it means to be at “high” or “elevated” risk for developing breast cancer? Do you know if you are at high risk?

Read more

External Story myVU myVU Take Note


Think Pink! Breast Cancer Awareness Expo is Oct. 4

Sep. 20, 2017—The Think Pink! Breast Cancer Awareness Expo will be held Wednesday, Oct. 4, from 11 a.m. to 1 p.m. in the Light Hall North Lobby.

Read more

External Story myVU myVU HR News


Are you a breast cancer survivor?

Sep. 18, 2017—Are you a breast cancer survivor? Health & Wellness would like to celebrate you and support breast cancer awareness by creating an “Awareness Saves Lives” faculty and staff survivor banner.

Read more

myVU myVU HR News


Breast Cancer Genomic Profiling Reveals Clues to Treatment Resistance

Aug. 9, 2017—Thanks to advances in treatment, the relative five-year survival rate from all combined subtypes of breast cancer now exceeds 90 percent and yet the disease remains the third leading cause of cancer deaths in the United States after lung and colorectal cancers.

Read more

Reporter


Stress may switch on bone “mets”

Aug. 9, 2017—New findings could explain the link between chronic stress and reduced survival in women diagnosed with breast cancer, and could lead to new strategies to improve treatment outcomes.

Read more

Health and Medicine Reporter Research


Investigators match novel cancer mutations with potential therapies

Aug. 3, 2017—Research led by Vanderbilt-Ingram Cancer Center (VICC) investigators may have solved a mystery about why a targeted therapy stops working in a small group of breast cancer patients.

Read more

Health and Medicine Reporter Research


Hijacking human proteins to better deliver anti-cancer drugs

Jul. 24, 2017—Vanderbilt University engineers find existing human protein is ideal carrier for powerful molecules that can signal tumors to self-destruct.

Read more

Engineering and Technology featured video Healthcare Solutions myVU myVU News releases Research research videos Strategic Plan vucast


Drivers of breast cancer metastasis

Jul. 20, 2017—Signaling through a complex of proteins called mTORC2 plays a role in breast cancer migration, invasion and metastasis, Vanderbilt researchers reported.

Read more

Health and Medicine Reporter Research


Arteaga to direct UT Southwestern cancer center

Jul. 13, 2017—Carlos L. Arteaga, M.D., director of the Center for Cancer Targeted Therapies (C2T2), director of the Breast Cancer Research Program and associate director for Clinical Research at Vanderbilt-Ingram Cancer Center (VICC), has been named director of the Harold C. Simmons Comprehensive Cancer Center and associate dean of Oncology Programs at the UT Southwestern Medical Center in Dallas.

Read more

Reporter


STINGing combination for cancer

Jun. 19, 2017—A novel immunotherapy combination induced remarkable regression of tumors in a mouse model of head and neck cancer.

Read more

Health and Medicine Reporter Research


Page 1 of 812345678